MedPath

The role of exhaled nitric oxide in patients with chronic obstructive pulmonary disease undergoing abdominal surgery

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Post-operative complications following abdominal surgery
Respiratory - Chronic obstructive pulmonary disease
Surgery - Other surgery
Registration Number
ACTRN12616000211460
Lead Sponsor
Faculty of Medicine, University of Thessaly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients scheduled for major abdominal surgeries that were evaluated from an experienced physician were enrolled for the study.
The inclusion criteria are:
- age 18-75 years
- a diagnosis of COPD according to the American Thoracic Society (ATS) criteria in a stable condition and free from exacerbations in the preceding four weeks
- ASA physical status II, III, IV
- Smoking patients

Exclusion Criteria

Patients with:
- other organ failure
- cancer
- inability to cooperate
- patients with a recent exacerbation (e.g. requiring hospitalization or oral corticosteroids)
- patients with another or coexisting respiratory disorder (e.g. COPD and bronchiectasis)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of this study was to evaluate the relationship between exhaled NO in COPD patients undergoing major abdominal surgeries and the risk of presenting postoperative complications<br>The postoperative complications as laryngospasm, bronchospasm, cough, dyspnea and tachypnea will be assessed using clinical examination combined with the recorded use of corticosteroids and bronchodilators. <br>The values of blood gases 1 and 3 hours postoperatively as well 3 days after surgery will be recorded using a blood gas analyzer. [Perioperatively and 1-3 days postoperatively]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath